Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 343

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 343
---
. The pro forma combined value information reflects the Merger as if it had occurred on December31, 2024, and is computed by multiplying the historical number of Kadimastem by the Exchange Ratio. The pro forma combined share information below does not purport to represent what the actual results of operations or the earnings per share would been had the companies combined during the periods presented, nor to project the combined company’s results of operations or earnings per share for any future date or period. The pro forma combined shareholders’ equity per share information below does not purport to represent what the value of NLS and Kadimastem would have been had the companies been combined during the periods presented. The unaudited pro forma book value information reflects the Merger as if occurred on December31, 2024. The weighted average shares outstanding and net earnings per share information reflect the Merger as if it had occurred on December31, 2024.

| As of and for the twelve months ended December 31,      
 2024 for NLS and Kadimastem                             |     | NLS          
 (Historical) |           |   |     | Kadimastem   
 (Historical) |           |   |     | Pro         
 Forma       
 Combined(2) |            |   |
|:--------------------------------------------------------|:----|:-------------|----------:|:--|:----|:-------------|----------:|:--|:----|:------------|-----------:|:--|
| Book value per share(1)                                 |     | $            |     (8.84 | ) |     | $            |     (0.52 | ) |     | $           |       0.41 |   |
| Weighted average outstanding shares (basic and diluted) |     |              | 1,048,632 |   |     |              | 4,193,689 |   |     |             | 39,385,272 |   |
| Weighted average loss per share (basic and diluted)     |     | $            |     (1.94 | ) |     | $            |     (0.03 | ) |     | $           |      (0.16 | ) |

____________ (1)Book value per share is calculated using the formula: total shareholders’ equity from the balance sheet as of December 31, 2024 divided by shares outstanding as of December 31, 2024. (2)The pro forma combined numbers include